HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients

Transfusion. 2021 Apr;61(4):1222-1234. doi: 10.1111/trf.16282. Epub 2021 Feb 13.

Abstract

Background: Patients can form antibodies to foreign human leukocyte antigen (HLA) Class I antigens after exposure to allogeneic cells. These anti-HLA class I antibodies can bind transfused platelets (PLTs) and mediate their destruction, thus leading to PLT refractoriness. Patients with PLT refractoriness need HLA-matched PLTs, which require expensive HLA typing of donors, antibody analyses of patient sera and/or crossmatching. An alternative approach is to reduce PLT HLA Class I expression using a brief incubation in citric acid on ice at low pH.

Methods and materials: Apheresis PLT concentrates were depleted of HLA Class I complexes by 5 minutes incubation in ice-cold citric acid, at pH 3.0. Surface expression of HLA Class I complexes, CD62P, CD63, phosphatidylserine, and complement factor C3c was analyzed by flow cytometry. PLT functionality was tested by thromboelastography (TEG).

Results: Acid treatment reduced the expression of HLA Class I complexes by 71% and potential for C3c binding by 11.5-fold compared to untreated PLTs. Acid-treated PLTs were significantly more activated than untreated PLTs, but irrespective of this increase in steady-state activation, CD62P and CD63 were strongly upregulated on both acid-treated and untreated PLTs after stimulation with thrombin receptor agonist peptide. Acid treatment did not induce apoptosis over time. X-ray irradiation did not significantly influence the expression of HLA Class I complexes, CD62P, CD63, and TEG variables on acid treated PLTs.

Conclusion: The relatively simple acid stripping method can be used with irradiated apheresis PLTs and may prevent transfusion-associated HLA sensitization and overcome PLT refractoriness.

Keywords: hematology - platelets; immune thrombocytopenia; platelet transfusion.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / immunology
  • Blood Grouping and Crossmatching / methods
  • Blood Platelets / radiation effects
  • Citric Acid / adverse effects*
  • Female
  • Histocompatibility Antigens Class I / drug effects*
  • Histocompatibility Antigens Class I / immunology
  • Histocompatibility Antigens Class I / metabolism
  • Histocompatibility Antigens Class I / radiation effects
  • Histocompatibility Testing / economics
  • Histocompatibility Testing / methods
  • Humans
  • P-Selectin / metabolism
  • Platelet Transfusion / adverse effects
  • Platelet Transfusion / methods*
  • Plateletpheresis / methods
  • Severe Combined Immunodeficiency / chemically induced*
  • Tetraspanin 30 / metabolism
  • Thrombelastography / methods
  • Thrombocytopenia / therapy
  • Up-Regulation / genetics

Substances

  • Antibodies
  • Histocompatibility Antigens Class I
  • P-Selectin
  • Tetraspanin 30
  • Citric Acid

Supplementary concepts

  • Bare Lymphocyte Syndrome, Type I